Department of Psychology and The Center for Neuroscience, University of Colorado at Boulder, Boulder, Colorado.
Department of Psychology and The Center for Neuroscience, University of Colorado at Boulder, Boulder, Colorado.
J Pain. 2014 Feb;15(2):121-8. doi: 10.1016/j.jpain.2013.10.001. Epub 2013 Oct 12.
Decreased voluntary wheel running has recently been proposed as a preclinical pain measure for inflammatory pain, but whether this reflects pain evoked by use of the affected limbs is unknown. To assess the role of inflammation site as a determinant of this measure, complete Freund's adjuvant (CFA), formalin, or equivolume vehicle was subcutaneously injected into the plantar surface of the hind paws (bilateral) or L1 dorsum dermatome (leaving paws unaffected) of male Sprague Dawley rats. CFA-induced hind paw mechanical allodynia (P < .001) did not correlate with reduced voluntary wheel running. Intraplantar formalin did not attenuate voluntary running, despite eliciting robust licking/writhing/flinching behavior and hind paw mechanical allodynia (P < .001). Subcutaneous L1 dorsum dermatome formalin, but not CFA, induced licking/writhing/flinching behavior (P < .001), but neither induced hind paw mechanical allodynia or attenuated voluntary running. That voluntary running is decreased by hind paw CFA, but not by L1 dorsum CFA, implies that the behavior is a measure of CFA-induced pain evoked by use of the affected limbs rather than supraspinal pain processing that is independent of inflammation site. Furthermore, the results suggest that interpretation of voluntary wheel running data cannot simply be explained by correlation with mechanical allodynia.
Whether decreased voluntary running is dependent on inflammation site is unknown. We show that intraplantar, but not L1 dorsum, CFA suppressed voluntary running and formalin-induced licking/writhing/flinching behavior but had no effect on voluntary running. These data suggest that suppressed voluntary running by CFA likely reflects pain evoked by use of the affected limbs.
最近提出减少自愿轮跑可作为炎症性疼痛的临床前疼痛测量指标,但尚不清楚这是否反映了使用受累肢体引起的疼痛。为了评估炎症部位作为该测量指标决定因素的作用,将完全弗氏佐剂(CFA)、福马林或等容量载体皮下注射到雄性 Sprague Dawley 大鼠的后爪足底表面(双侧)或 L1 背侧皮节(不影响爪子)。CFA 诱导的后爪机械性痛觉过敏(P<.001)与自愿轮跑减少无关。尽管福马林皮下注射到足底不会减弱自愿跑步,但会引起强烈的舔舐/扭动/畏缩行为和后爪机械性痛觉过敏(P<.001)。皮下 L1 背侧皮节福马林,但不是 CFA,会引起舔舐/扭动/畏缩行为(P<.001),但都不会引起后爪机械性痛觉过敏或减弱自愿跑步。自愿跑步因后爪 CFA 而减少,但不因 L1 背侧 CFA 而减少,这意味着该行为是对受累肢体引起的 CFA 诱导疼痛的测量,而不是与炎症部位无关的脊髓上疼痛处理。此外,结果表明,不能简单地通过与机械性痛觉过敏的相关性来解释自愿轮跑数据的解释。
自愿跑步是否依赖于炎症部位尚不清楚。我们发现,足底而非 L1 背侧 CFA 抑制了自愿跑步和福马林诱导的舔舐/扭动/畏缩行为,但对自愿跑步没有影响。这些数据表明,CFA 引起的自愿跑步减少可能反映了受累肢体引起的疼痛。